Variant report
Variant | rs61784833 |
---|---|
Chromosome Location | chr1:46233772-46233773 |
allele | C/T |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:7)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:7 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr1:46214485..46216024-chr1:46233125..46235612,2 | K562 | blood: | |
2 | chr1:46232525..46235856-chr1:46237252..46240769,3 | K562 | blood: | |
3 | chr1:46233422..46236308-chr1:46241292..46243048,2 | K562 | blood: | |
4 | chr1:46216677..46220436-chr1:46232703..46236378,4 | K562 | blood: | |
5 | chr1:46232525..46235856-chr1:46236169..46240769,5 | K562 | blood: | |
6 | chr1:46151070..46155000-chr1:46230734..46234846,4 | K562 | blood: | |
7 | chr1:46214524..46222325-chr1:46232703..46237007,10 | K562 | blood: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000197429 | Chromatin interaction |
ENSG00000159592 | Chromatin interaction |
ENSG00000159596 | Chromatin interaction |
rs_ID | r2[population] |
---|---|
rs10157795 | 0.88[AMR][1000 genomes];0.92[EUR][1000 genomes];0.98[ASN][1000 genomes] |
rs10430105 | 0.86[AMR][1000 genomes] |
rs10430123 | 0.80[AFR][1000 genomes];0.96[AMR][1000 genomes];0.91[EUR][1000 genomes];0.97[ASN][1000 genomes] |
rs10430124 | 0.80[AFR][1000 genomes];0.96[AMR][1000 genomes];0.91[EUR][1000 genomes];0.97[ASN][1000 genomes] |
rs10749856 | 0.91[AMR][1000 genomes];0.86[EUR][1000 genomes];0.93[ASN][1000 genomes] |
rs10789467 | 0.84[AMR][1000 genomes];0.87[ASN][1000 genomes] |
rs10789468 | 0.81[AMR][1000 genomes];0.81[EUR][1000 genomes];0.88[ASN][1000 genomes] |
rs10789470 | 0.91[AMR][1000 genomes];0.83[EUR][1000 genomes];0.90[ASN][1000 genomes] |
rs10789471 | 0.96[AMR][1000 genomes];0.90[EUR][1000 genomes] |
rs10789474 | 0.80[AFR][1000 genomes];0.91[AMR][1000 genomes];0.83[EUR][1000 genomes] |
rs10890333 | 0.82[AMR][1000 genomes];0.84[ASN][1000 genomes] |
rs10890334 | 0.82[AMR][1000 genomes] |
rs10890335 | 0.82[AMR][1000 genomes] |
rs10890336 | 0.82[AMR][1000 genomes];0.87[ASN][1000 genomes] |
rs10890337 | 0.84[AMR][1000 genomes];0.81[EUR][1000 genomes];0.88[ASN][1000 genomes] |
rs10890340 | 0.84[AMR][1000 genomes] |
rs10890341 | 0.89[AMR][1000 genomes];0.80[EUR][1000 genomes] |
rs10890342 | 0.88[AMR][1000 genomes];0.82[EUR][1000 genomes] |
rs10890343 | 0.84[AMR][1000 genomes];0.82[EUR][1000 genomes];0.90[ASN][1000 genomes] |
rs10890344 | 0.91[AMR][1000 genomes];0.86[EUR][1000 genomes];0.93[ASN][1000 genomes] |
rs10890345 | 0.94[AMR][1000 genomes];0.90[EUR][1000 genomes] |
rs10890346 | 1.00[AFR][1000 genomes];0.96[AMR][1000 genomes];0.91[EUR][1000 genomes];0.98[ASN][1000 genomes] |
rs10890347 | 0.87[AFR][1000 genomes];0.92[AMR][1000 genomes];0.84[EUR][1000 genomes];0.81[ASN][1000 genomes] |
rs10890348 | 0.87[AFR][1000 genomes];0.91[AMR][1000 genomes];0.84[EUR][1000 genomes];0.81[ASN][1000 genomes] |
rs11211145 | 0.82[AMR][1000 genomes] |
rs11211146 | 0.82[AMR][1000 genomes] |
rs11211147 | 0.82[AMR][1000 genomes] |
rs11211149 | 0.82[AMR][1000 genomes] |
rs11211151 | 0.82[AMR][1000 genomes];0.87[ASN][1000 genomes] |
rs11211152 | 0.82[AMR][1000 genomes] |
rs11211157 | 0.85[AMR][1000 genomes];0.81[EUR][1000 genomes];0.88[ASN][1000 genomes] |
rs11211158 | 0.84[AMR][1000 genomes];0.80[EUR][1000 genomes];0.88[ASN][1000 genomes] |
rs11211159 | 0.86[AMR][1000 genomes];0.90[ASN][1000 genomes] |
rs11211160 | 0.81[AMR][1000 genomes] |
rs11211161 | 0.89[AMR][1000 genomes];0.80[EUR][1000 genomes] |
rs11211162 | 0.89[AMR][1000 genomes];0.80[EUR][1000 genomes] |
rs11211163 | 0.89[AMR][1000 genomes];0.82[EUR][1000 genomes];0.90[ASN][1000 genomes] |
rs11211165 | 0.90[AMR][1000 genomes];0.82[EUR][1000 genomes];0.90[ASN][1000 genomes] |
rs11211166 | 0.90[AMR][1000 genomes];0.82[EUR][1000 genomes];0.90[ASN][1000 genomes] |
rs11211168 | 0.91[AMR][1000 genomes];0.84[EUR][1000 genomes] |
rs11211169 | 0.91[AMR][1000 genomes];0.85[EUR][1000 genomes] |
rs11211170 | 0.91[AMR][1000 genomes];0.85[EUR][1000 genomes] |
rs11211171 | 0.94[AMR][1000 genomes];0.86[EUR][1000 genomes] |
rs11211173 | 0.96[AMR][1000 genomes];0.89[EUR][1000 genomes] |
rs11211174 | 0.80[AFR][1000 genomes];0.96[AMR][1000 genomes];0.91[EUR][1000 genomes];0.97[ASN][1000 genomes] |
rs11211175 | 0.89[AMR][1000 genomes];0.91[EUR][1000 genomes];0.97[ASN][1000 genomes] |
rs11211176 | 0.94[ASN][1000 genomes] |
rs11211177 | 1.00[AFR][1000 genomes];0.96[AMR][1000 genomes];0.90[EUR][1000 genomes] |
rs11211178 | 1.00[AFR][1000 genomes];0.95[AMR][1000 genomes];0.92[EUR][1000 genomes];0.98[ASN][1000 genomes] |
rs11211179 | 0.88[AMR][1000 genomes];0.92[EUR][1000 genomes];0.98[ASN][1000 genomes] |
rs11211181 | 0.86[AMR][1000 genomes];0.92[EUR][1000 genomes];0.98[ASN][1000 genomes] |
rs11211182 | 0.84[AFR][1000 genomes];0.92[AMR][1000 genomes];0.83[EUR][1000 genomes] |
rs11488313 | 0.92[AFR][1000 genomes];0.96[AMR][1000 genomes];0.91[EUR][1000 genomes] |
rs12022141 | 0.97[AFR][1000 genomes];0.94[AMR][1000 genomes];0.86[EUR][1000 genomes];0.90[ASN][1000 genomes] |
rs12022673 | 0.81[AMR][1000 genomes] |
rs12023439 | 0.82[AMR][1000 genomes] |
rs12024590 | 0.84[AMR][1000 genomes] |
rs12025613 | 0.82[AMR][1000 genomes] |
rs12025621 | 0.95[ASN][1000 genomes] |
rs12027622 | 0.84[AMR][1000 genomes] |
rs12031182 | 0.80[AFR][1000 genomes];0.96[AMR][1000 genomes];0.91[EUR][1000 genomes];0.97[ASN][1000 genomes] |
rs12037803 | 0.89[AMR][1000 genomes];0.82[EUR][1000 genomes];0.90[ASN][1000 genomes] |
rs12041197 | 0.82[AMR][1000 genomes] |
rs12041677 | 0.86[AMR][1000 genomes] |
rs12043945 | 0.82[AMR][1000 genomes];0.84[ASN][1000 genomes] |
rs12045096 | 0.82[AMR][1000 genomes];0.87[ASN][1000 genomes] |
rs12047629 | 0.91[AMR][1000 genomes];0.82[EUR][1000 genomes] |
rs12048866 | 0.84[AMR][1000 genomes] |
rs12049027 | 0.84[AMR][1000 genomes];0.87[ASN][1000 genomes] |
rs12062535 | 0.87[AFR][1000 genomes];0.96[AMR][1000 genomes];0.90[EUR][1000 genomes] |
rs12069121 | 0.96[AFR][1000 genomes];0.96[AMR][1000 genomes];0.93[EUR][1000 genomes];0.94[ASN][1000 genomes] |
rs12070775 | 0.84[AMR][1000 genomes] |
rs12076580 | 0.90[AMR][1000 genomes] |
rs12081175 | 0.84[AMR][1000 genomes] |
rs12091503 | 0.82[AMR][1000 genomes];0.87[ASN][1000 genomes] |
rs12097761 | 0.82[AMR][1000 genomes] |
rs12402590 | 0.84[AFR][1000 genomes];0.91[AMR][1000 genomes];0.84[EUR][1000 genomes];0.81[ASN][1000 genomes] |
rs12404197 | 0.91[ASN][1000 genomes] |
rs1250 | 0.83[ASN][1000 genomes] |
rs12564201 | 0.93[AMR][1000 genomes];0.91[EUR][1000 genomes];0.96[ASN][1000 genomes] |
rs1541131 | 0.83[ASN][1000 genomes] |
rs1547924 | 0.80[ASN][1000 genomes] |
rs2275085 | 0.83[ASN][1000 genomes] |
rs28361459 | 0.91[AMR][1000 genomes];0.87[EUR][1000 genomes];0.91[ASN][1000 genomes] |
rs28370457 | 0.94[AMR][1000 genomes];0.86[EUR][1000 genomes] |
rs28375469 | 0.94[AMR][1000 genomes];0.87[EUR][1000 genomes];0.81[ASN][1000 genomes] |
rs28376548 | 0.86[AMR][1000 genomes];0.90[EUR][1000 genomes];0.87[ASN][1000 genomes] |
rs28378621 | 0.94[ASN][1000 genomes] |
rs28396194 | 0.94[AMR][1000 genomes];0.90[EUR][1000 genomes];0.81[ASN][1000 genomes] |
rs28406914 | 0.96[AMR][1000 genomes];0.88[EUR][1000 genomes];0.97[ASN][1000 genomes] |
rs28432365 | 0.96[AMR][1000 genomes];0.88[EUR][1000 genomes];0.97[ASN][1000 genomes] |
rs28438704 | 0.94[AMR][1000 genomes];0.87[EUR][1000 genomes];0.93[ASN][1000 genomes] |
rs28441217 | 0.92[AMR][1000 genomes];0.86[EUR][1000 genomes] |
rs28442079 | 0.92[AMR][1000 genomes];0.87[EUR][1000 genomes];0.93[ASN][1000 genomes] |
rs28456069 | 0.90[AMR][1000 genomes];0.90[ASN][1000 genomes] |
rs28474773 | 0.96[AMR][1000 genomes];0.88[EUR][1000 genomes];0.97[ASN][1000 genomes] |
rs28490344 | 0.91[AMR][1000 genomes];0.87[EUR][1000 genomes];0.97[ASN][1000 genomes] |
rs28495425 | 0.96[AMR][1000 genomes];0.88[EUR][1000 genomes];0.97[ASN][1000 genomes] |
rs28498557 | 0.88[AMR][1000 genomes];0.86[EUR][1000 genomes];0.95[ASN][1000 genomes] |
rs28501477 | 0.93[AMR][1000 genomes];0.87[EUR][1000 genomes];0.96[ASN][1000 genomes] |
rs28507722 | 0.94[AMR][1000 genomes];0.89[EUR][1000 genomes];0.81[ASN][1000 genomes] |
rs28508523 | 0.81[EUR][1000 genomes];0.83[ASN][1000 genomes] |
rs28513660 | 0.91[AMR][1000 genomes];0.86[EUR][1000 genomes];0.81[ASN][1000 genomes] |
rs28528139 | 0.91[AMR][1000 genomes];0.87[EUR][1000 genomes];0.90[ASN][1000 genomes] |
rs28545085 | 0.94[AMR][1000 genomes];0.89[EUR][1000 genomes];0.81[ASN][1000 genomes] |
rs28550303 | 0.96[AMR][1000 genomes];0.87[EUR][1000 genomes];0.81[ASN][1000 genomes] |
rs28564319 | 0.95[AMR][1000 genomes];0.88[EUR][1000 genomes];0.97[ASN][1000 genomes] |
rs28568986 | 0.94[AMR][1000 genomes];0.89[EUR][1000 genomes] |
rs28594599 | 0.94[AMR][1000 genomes];0.82[EUR][1000 genomes] |
rs28597977 | 0.93[AMR][1000 genomes];0.81[EUR][1000 genomes] |
rs28607263 | 0.90[AMR][1000 genomes];0.87[EUR][1000 genomes] |
rs28617418 | 0.96[AMR][1000 genomes];0.87[EUR][1000 genomes];0.90[ASN][1000 genomes] |
rs28623463 | 0.94[AMR][1000 genomes];0.86[EUR][1000 genomes] |
rs28635845 | 0.92[ASN][1000 genomes] |
rs28641748 | 0.94[AMR][1000 genomes];0.88[EUR][1000 genomes];0.97[ASN][1000 genomes] |
rs28647556 | 0.94[ASN][1000 genomes] |
rs28683093 | 0.85[AMR][1000 genomes];0.86[EUR][1000 genomes];0.90[ASN][1000 genomes] |
rs28719889 | 0.94[AMR][1000 genomes];0.87[EUR][1000 genomes] |
rs28752166 | 0.94[AMR][1000 genomes];0.90[EUR][1000 genomes];0.81[ASN][1000 genomes] |
rs28789495 | 0.95[AMR][1000 genomes];0.88[EUR][1000 genomes];0.97[ASN][1000 genomes] |
rs28812624 | 0.94[AMR][1000 genomes];0.89[EUR][1000 genomes] |
rs28817701 | 0.96[AMR][1000 genomes];0.88[EUR][1000 genomes];0.97[ASN][1000 genomes] |
rs28844317 | 0.94[ASN][1000 genomes] |
rs28862324 | 0.96[AMR][1000 genomes];0.87[EUR][1000 genomes] |
rs28890893 | 0.96[AMR][1000 genomes];0.87[EUR][1000 genomes] |
rs2991985 | 0.80[ASN][1000 genomes] |
rs2991986 | 0.83[ASN][1000 genomes] |
rs2991987 | 0.83[ASN][1000 genomes] |
rs3013594 | 0.81[ASN][1000 genomes] |
rs3013595 | 0.87[ASN][1000 genomes] |
rs3013596 | 0.87[ASN][1000 genomes] |
rs3013597 | 0.87[ASN][1000 genomes] |
rs3014236 | 0.83[ASN][1000 genomes] |
rs3014238 | 0.81[ASN][1000 genomes] |
rs3014239 | 0.83[ASN][1000 genomes] |
rs3014243 | 0.90[ASN][1000 genomes] |
rs3014247 | 0.84[ASN][1000 genomes] |
rs34895634 | 0.93[AFR][1000 genomes];0.96[AMR][1000 genomes];0.93[EUR][1000 genomes];0.97[ASN][1000 genomes] |
rs3811435 | 0.84[AMR][1000 genomes];0.81[EUR][1000 genomes];0.88[ASN][1000 genomes] |
rs3811436 | 0.84[AMR][1000 genomes];0.80[EUR][1000 genomes] |
rs3935296 | 0.96[AMR][1000 genomes];0.88[EUR][1000 genomes];0.97[ASN][1000 genomes] |
rs4274104 | 0.94[ASN][1000 genomes] |
rs4275489 | 0.80[AFR][1000 genomes];0.92[AMR][1000 genomes];0.83[EUR][1000 genomes] |
rs4330955 | 0.80[AFR][1000 genomes];0.96[AMR][1000 genomes];0.89[EUR][1000 genomes];0.94[ASN][1000 genomes] |
rs4415615 | 0.81[AMR][1000 genomes] |
rs4423054 | 0.96[AMR][1000 genomes];0.92[EUR][1000 genomes];0.97[ASN][1000 genomes] |
rs4431884 | 0.84[ASN][1000 genomes] |
rs4439382 | 0.89[AMR][1000 genomes];0.80[EUR][1000 genomes] |
rs4468203 | 0.86[ASN][1000 genomes] |
rs4508055 | 0.89[AMR][1000 genomes] |
rs4559551 | 0.91[AMR][1000 genomes];0.87[EUR][1000 genomes];0.93[ASN][1000 genomes] |
rs4564187 | 0.91[AMR][1000 genomes];0.87[EUR][1000 genomes];0.93[ASN][1000 genomes] |
rs4586014 | 0.89[AMR][1000 genomes];0.81[EUR][1000 genomes] |
rs4607935 | 0.84[AMR][1000 genomes] |
rs4607936 | 0.80[AFR][1000 genomes];0.92[AMR][1000 genomes];0.82[EUR][1000 genomes] |
rs4609469 | 0.84[AMR][1000 genomes];0.87[ASN][1000 genomes] |
rs4630155 | 0.90[AMR][1000 genomes] |
rs4660312 | 0.86[ASN][1000 genomes] |
rs4660314 | 1.00[AFR][1000 genomes];0.96[AMR][1000 genomes];0.92[EUR][1000 genomes];0.98[ASN][1000 genomes] |
rs4660879 | 0.80[ASN][1000 genomes] |
rs4660880 | 0.82[AMR][1000 genomes] |
rs4660882 | 0.86[ASN][1000 genomes] |
rs4660883 | 1.00[AFR][1000 genomes];0.96[AMR][1000 genomes];0.92[EUR][1000 genomes];0.98[ASN][1000 genomes] |
rs5021934 | 0.86[ASN][1000 genomes] |
rs56177313 | 1.00[AFR][1000 genomes];0.95[AMR][1000 genomes];0.92[EUR][1000 genomes];0.98[ASN][1000 genomes] |
rs56255771 | 0.88[AMR][1000 genomes];0.92[EUR][1000 genomes];0.98[ASN][1000 genomes] |
rs59916372 | 0.95[AFR][1000 genomes];0.96[AMR][1000 genomes];0.91[EUR][1000 genomes];0.98[ASN][1000 genomes] |
rs61062981 | 0.94[AMR][1000 genomes];0.89[EUR][1000 genomes];0.81[ASN][1000 genomes] |
rs61784793 | 0.89[AMR][1000 genomes];0.80[EUR][1000 genomes] |
rs61784795 | 0.89[AMR][1000 genomes];0.81[EUR][1000 genomes] |
rs61784796 | 0.91[AMR][1000 genomes];0.85[EUR][1000 genomes];0.91[ASN][1000 genomes] |
rs61784799 | 0.94[AMR][1000 genomes];0.87[EUR][1000 genomes] |
rs61784800 | 0.82[AMR][1000 genomes];0.87[EUR][1000 genomes];0.95[ASN][1000 genomes] |
rs61784801 | 0.93[AMR][1000 genomes];0.81[EUR][1000 genomes] |
rs61784803 | 0.96[AMR][1000 genomes];0.88[EUR][1000 genomes];0.97[ASN][1000 genomes] |
rs61784821 | 0.91[AMR][1000 genomes] |
rs61784824 | 0.90[AMR][1000 genomes];0.83[EUR][1000 genomes];0.89[ASN][1000 genomes] |
rs6429574 | 0.81[AMR][1000 genomes];0.80[EUR][1000 genomes];0.88[ASN][1000 genomes] |
rs6429575 | 0.84[AMR][1000 genomes];0.80[EUR][1000 genomes];0.88[ASN][1000 genomes] |
rs6429576 | 0.93[ASN][1000 genomes] |
rs6656279 | 0.87[ASN][1000 genomes] |
rs6658700 | 0.91[AMR][1000 genomes];0.83[EUR][1000 genomes] |
rs6665808 | 0.82[AMR][1000 genomes];0.84[EUR][1000 genomes];0.91[ASN][1000 genomes] |
rs66682726 | 0.88[AMR][1000 genomes] |
rs6671802 | 0.87[ASN][1000 genomes] |
rs6672115 | 0.87[AMR][1000 genomes] |
rs6678444 | 0.99[AFR][1000 genomes];0.95[AMR][1000 genomes];0.91[EUR][1000 genomes] |
rs6683274 | 0.92[AMR][1000 genomes];0.84[EUR][1000 genomes];0.81[ASN][1000 genomes] |
rs6686944 | 0.85[AMR][1000 genomes];0.86[ASN][1000 genomes] |
rs6690386 | 0.81[AFR][1000 genomes];0.92[AMR][1000 genomes] |
rs6690775 | 0.80[AFR][1000 genomes];0.91[AMR][1000 genomes] |
rs6690926 | 0.86[AMR][1000 genomes];0.80[EUR][1000 genomes];0.90[ASN][1000 genomes] |
rs6694889 | 0.82[AMR][1000 genomes] |
rs6697821 | 0.96[AMR][1000 genomes];0.89[EUR][1000 genomes];0.96[ASN][1000 genomes] |
rs6699418 | 0.84[ASN][1000 genomes] |
rs6699444 | 0.86[AMR][1000 genomes] |
rs6703960 | 0.95[ASN][1000 genomes] |
rs71500087 | 0.85[AMR][1000 genomes] |
rs72688483 | 0.87[ASN][1000 genomes] |
rs7519900 | 1.00[AFR][1000 genomes];0.96[AMR][1000 genomes];0.92[EUR][1000 genomes];0.98[ASN][1000 genomes] |
rs7520123 | 0.86[AMR][1000 genomes];0.92[EUR][1000 genomes];0.98[ASN][1000 genomes] |
rs7529699 | 0.84[AMR][1000 genomes] |
rs7539800 | 0.87[AMR][1000 genomes] |
rs7540578 | 0.92[AMR][1000 genomes];0.84[EUR][1000 genomes];0.81[ASN][1000 genomes] |
rs7541962 | 1.00[AFR][1000 genomes];0.96[AMR][1000 genomes];0.91[EUR][1000 genomes] |
rs8179296 | 0.89[AMR][1000 genomes];0.80[EUR][1000 genomes];0.90[ASN][1000 genomes] |
rs8179402 | 0.89[AMR][1000 genomes];0.80[EUR][1000 genomes];0.90[ASN][1000 genomes] |
rs9793568 | 0.83[AMR][1000 genomes];0.88[ASN][1000 genomes] |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | nsv529631 | chr1:45905936-46335246 | Enhancers Flanking Active TSS Transcr. at gene 5' and 3' Strong transcription Weak transcription Active TSS Genic enhancers ZNF genes & repeats Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 207 gene(s) | inside rSNPs | diseases |
2 | nsv932680 | chr1:45935520-46686477 | Strong transcription Weak transcription Flanking Active TSS Active TSS Enhancers Genic enhancers Bivalent/Poised TSS Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Bivalent Enhancer ZNF genes & repeats | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 232 gene(s) | inside rSNPs | diseases |
3 | nsv868828 | chr1:45953923-46686477 | Active TSS Weak transcription Enhancers Flanking Active TSS Strong transcription Genic enhancers Bivalent/Poised TSS Transcr. at gene 5' and 3' ZNF genes & repeats Flanking Bivalent TSS/Enh Bivalent Enhancer | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 232 gene(s) | inside rSNPs | diseases |
4 | nsv871928 | chr1:46024701-46609736 | Weak transcription Enhancers ZNF genes & repeats Strong transcription Active TSS Genic enhancers Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Transcr. at gene 5' and 3' Bivalent/Poised TSS | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 123 gene(s) | inside rSNPs | diseases |
5 | nsv1011587 | chr1:46051672-46244492 | Enhancers Weak transcription Flanking Active TSS Strong transcription Active TSS Genic enhancers Transcr. at gene 5' and 3' ZNF genes & repeats Bivalent Enhancer Bivalent/Poised TSS | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 79 gene(s) | inside rSNPs | diseases |
6 | nsv1014128 | chr1:46097670-46394540 | Weak transcription Flanking Active TSS Strong transcription Active TSS Enhancers Genic enhancers Transcr. at gene 5' and 3' ZNF genes & repeats Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 77 gene(s) | inside rSNPs | diseases |
7 | nsv1010054 | chr1:46144479-46320493 | Active TSS Weak transcription Enhancers Flanking Active TSS Strong transcription ZNF genes & repeats Genic enhancers Transcr. at gene 5' and 3' Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 75 gene(s) | inside rSNPs | diseases |
8 | nsv1006861 | chr1:46144479-46417621 | Weak transcription Enhancers ZNF genes & repeats Strong transcription Flanking Active TSS Active TSS Genic enhancers Transcr. at gene 5' and 3' Bivalent Enhancer Flanking Bivalent TSS/Enh Bivalent/Poised TSS | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 76 gene(s) | inside rSNPs | diseases |
9 | nsv1003049 | chr1:46144479-46476149 | Enhancers Weak transcription Active TSS Flanking Active TSS Strong transcription ZNF genes & repeats Bivalent Enhancer Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Genic enhancers Bivalent/Poised TSS | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 78 gene(s) | inside rSNPs | diseases |
10 | nsv870511 | chr1:46148138-46245423 | Enhancers Active TSS Strong transcription Weak transcription Flanking Active TSS ZNF genes & repeats Transcr. at gene 5' and 3' Genic enhancers Bivalent Enhancer Bivalent/Poised TSS | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 71 gene(s) | inside rSNPs | diseases |
11 | nsv871233 | chr1:46153203-46311275 | Strong transcription Enhancers Weak transcription Flanking Active TSS Active TSS Transcr. at gene 5' and 3' ZNF genes & repeats Genic enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh Bivalent/Poised TSS | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 61 gene(s) | inside rSNPs | diseases |
12 | nsv1008219 | chr1:46160098-46493958 | Genic enhancers Strong transcription ZNF genes & repeats Weak transcription Enhancers Flanking Active TSS Active TSS Bivalent Enhancer Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Bivalent/Poised TSS | TF binding regionCpG islandChromatin interactive regionlncRNA | 42 gene(s) | inside rSNPs | diseases |
13 | nsv534943 | chr1:46160098-46493958 | Enhancers Flanking Active TSS Strong transcription Weak transcription Bivalent Enhancer Active TSS ZNF genes & repeats Transcr. at gene 5' and 3' Genic enhancers Flanking Bivalent TSS/Enh Bivalent/Poised TSS | TF binding regionCpG islandChromatin interactive regionlncRNA | 42 gene(s) | inside rSNPs | diseases |
14 | nsv1000498 | chr1:46171836-46438252 | Weak transcription ZNF genes & repeats Enhancers Strong transcription Active TSS Flanking Active TSS Genic enhancers Bivalent Enhancer Transcr. at gene 5' and 3' Bivalent/Poised TSS Flanking Bivalent TSS/Enh | TF binding regionCpG islandChromatin interactive regionlncRNA | 39 gene(s) | inside rSNPs | diseases |
15 | nsv870791 | chr1:46182916-46398415 | Enhancers Weak transcription Active TSS Flanking Active TSS Genic enhancers Strong transcription ZNF genes & repeats Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Bivalent Enhancer Bivalent/Poised TSS | TF binding regionCpG islandChromatin interactive regionlncRNA | 38 gene(s) | inside rSNPs | diseases |
16 | nsv871023 | chr1:46184300-46301182 | Weak transcription Strong transcription Active TSS Flanking Active TSS Enhancers Bivalent Enhancer ZNF genes & repeats Genic enhancers Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Bivalent/Poised TSS | TF binding regionCpG islandChromatin interactive regionlncRNA | 36 gene(s) | inside rSNPs | diseases |
17 | nsv998925 | chr1:46184925-46353041 | Weak transcription Flanking Active TSS Enhancers Strong transcription Active TSS Genic enhancers Bivalent Enhancer ZNF genes & repeats Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Bivalent/Poised TSS | TF binding regionCpG islandChromatin interactive regionlncRNA | 37 gene(s) | inside rSNPs | diseases |
18 | nsv1003986 | chr1:46184925-46417621 | Active TSS Weak transcription Enhancers Flanking Active TSS Strong transcription Transcr. at gene 5' and 3' Genic enhancers ZNF genes & repeats Bivalent Enhancer Flanking Bivalent TSS/Enh Bivalent/Poised TSS | TF binding regionCpG islandChromatin interactive regionlncRNA | 39 gene(s) | inside rSNPs | diseases |
19 | nsv1007501 | chr1:46184925-46439533 | Enhancers Weak transcription Strong transcription Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS ZNF genes & repeats Genic enhancers Bivalent Enhancer Transcr. at gene 5' and 3' Bivalent/Poised TSS | TF binding regionCpG islandChromatin interactive regionlncRNA | 39 gene(s) | inside rSNPs | diseases |
20 | nsv534944 | chr1:46184925-46439533 | Enhancers Weak transcription Strong transcription Flanking Active TSS Bivalent Enhancer Active TSS ZNF genes & repeats Flanking Bivalent TSS/Enh Genic enhancers Transcr. at gene 5' and 3' Bivalent/Poised TSS | TF binding regionCpG islandChromatin interactive regionlncRNA | 39 gene(s) | inside rSNPs | diseases |
21 | nsv871763 | chr1:46186576-46236098 | Weak transcription Strong transcription Enhancers Active TSS Flanking Active TSS Bivalent Enhancer ZNF genes & repeats Genic enhancers Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNA | 31 gene(s) | inside rSNPs | diseases |
22 | nsv1006891 | chr1:46189258-46408032 | Weak transcription Flanking Active TSS Enhancers Active TSS Strong transcription Transcr. at gene 5' and 3' Genic enhancers Bivalent Enhancer ZNF genes & repeats Flanking Bivalent TSS/Enh Bivalent/Poised TSS | TF binding regionCpG islandChromatin interactive regionlncRNA | 38 gene(s) | inside rSNPs | diseases |
23 | nsv1009355 | chr1:46189258-46463012 | Active TSS Genic enhancers ZNF genes & repeats Enhancers Flanking Active TSS Strong transcription Weak transcription Bivalent Enhancer Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Bivalent/Poised TSS | TF binding regionCpG islandChromatin interactive regionlncRNA | 39 gene(s) | inside rSNPs | diseases |
24 | nsv870626 | chr1:46196813-46314170 | Weak transcription Active TSS Enhancers Flanking Active TSS Strong transcription Bivalent Enhancer Genic enhancers ZNF genes & repeats Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Bivalent/Poised TSS | TF binding regionCpG islandChromatin interactive regionlncRNA | 37 gene(s) | inside rSNPs | diseases |
25 | nsv871312 | chr1:46196813-46353332 | Enhancers Active TSS Flanking Active TSS Weak transcription Transcr. at gene 5' and 3' ZNF genes & repeats Strong transcription Genic enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer Bivalent/Poised TSS | TF binding regionCpG islandChromatin interactive regionlncRNA | 37 gene(s) | inside rSNPs | diseases |
26 | esv2830426 | chr1:46202361-46347367 | Active TSS Enhancers Strong transcription Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh ZNF genes & repeats Bivalent Enhancer Transcr. at gene 5' and 3' Genic enhancers Bivalent/Poised TSS | TF binding regionCpG islandChromatin interactive regionlncRNA | 37 gene(s) | inside rSNPs | diseases |
27 | nsv546158 | chr1:46216575-46495434 | Flanking Active TSS Weak transcription Active TSS Enhancers Strong transcription Bivalent Enhancer Genic enhancers ZNF genes & repeats Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Bivalent/Poised TSS | TF binding regionCpG islandChromatin interactive regionlncRNA | 30 gene(s) | inside rSNPs | diseases |
28 | nsv870911 | chr1:46216575-46498375 | Enhancers Weak transcription Flanking Active TSS Genic enhancers Active TSS Strong transcription ZNF genes & repeats Bivalent Enhancer Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Bivalent/Poised TSS | TF binding regionCpG islandChromatin interactive regionlncRNA | 32 gene(s) | inside rSNPs | diseases |
29 | nsv1013628 | chr1:46221617-46356565 | Enhancers Flanking Active TSS Strong transcription Weak transcription Active TSS ZNF genes & repeats Bivalent Enhancer Genic enhancers Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Bivalent/Poised TSS | TF binding regionCpG islandChromatin interactive region | 12 gene(s) | inside rSNPs | diseases |
30 | nsv431268 | chr1:46223080-46495480 | Strong transcription Enhancers Weak transcription Flanking Active TSS Genic enhancers ZNF genes & repeats Active TSS Transcr. at gene 5' and 3' Bivalent Enhancer Flanking Bivalent TSS/Enh Bivalent/Poised TSS | TF binding regionCpG islandChromatin interactive regionlncRNA | 17 gene(s) | inside rSNPs | diseases |
31 | nsv546159 | chr1:46223086-46398415 | Enhancers Strong transcription Genic enhancers Weak transcription Active TSS Flanking Active TSS Bivalent Enhancer ZNF genes & repeats Transcr. at gene 5' and 3' Bivalent/Poised TSS Flanking Bivalent TSS/Enh | TF binding regionCpG islandChromatin interactive regionlncRNA | 13 gene(s) | inside rSNPs | diseases |
32 | nsv461417 | chr1:46223086-46416348 | Weak transcription Active TSS Flanking Active TSS Enhancers Strong transcription ZNF genes & repeats Bivalent Enhancer Transcr. at gene 5' and 3' Genic enhancers Flanking Bivalent TSS/Enh Bivalent/Poised TSS | TF binding regionCpG islandChromatin interactive regionlncRNA | 14 gene(s) | inside rSNPs | diseases |
33 | nsv546160 | chr1:46223086-46416348 | ZNF genes & repeats Enhancers Weak transcription Flanking Active TSS Strong transcription Active TSS Bivalent Enhancer Transcr. at gene 5' and 3' Genic enhancers Flanking Bivalent TSS/Enh Bivalent/Poised TSS | TF binding regionCpG islandChromatin interactive regionlncRNA | 14 gene(s) | inside rSNPs | diseases |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr1:46232000-46234000 | Weak transcription | H1 Derived Mesenchymal Stem Cells | ES cell derived |
2 | chr1:46232000-46236200 | Weak transcription | HepG2 | liver |
3 | chr1:46232400-46234400 | Weak transcription | K562 | blood |
4 | chr1:46233000-46234400 | Weak transcription | NH-A | brain |
5 | chr1:46233200-46233800 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
6 | chr1:46233200-46234400 | Weak transcription | IMR90 fetal lung fibroblasts Cell Line | lung |
7 | chr1:46233200-46234600 | Weak transcription | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
8 | chr1:46233200-46234600 | Weak transcription | Muscle Satellite Cultured Cells | -- |
9 | chr1:46233200-46234800 | Weak transcription | Osteobl | bone |
10 | chr1:46233400-46234400 | Weak transcription | Foreskin Fibroblast Primary Cells skin01 | Skin |
11 | chr1:46233600-46233800 | Enhancers | Skeletal Muscle Female | skeletal muscle |
12 | chr1:46233600-46234000 | Weak transcription | Fetal Muscle Leg | muscle |